167 related articles for article (PubMed ID: 7677438)
1. IgA1 and IgA2 subclass antibodies against Klebsiella pneumoniae in the sera of patients with peripheral and axial types of ankylosing spondylitis.
Mäki-Ikola O; Nissilä M; Lehtinen K; Leirisalo-Repo M; Granfors K
Ann Rheum Dis; 1995 Aug; 54(8):631-5. PubMed ID: 7677438
[TBL] [Abstract][Full Text] [Related]
2. Similarly increased serum IgA1 and IgA2 subclass antibody levels against Klebsiella pneumoniae bacteria in ankylosing spondylitis patients with/without extra-articular features.
Mäki-Ikola O; Lehtinen K; Granfors K
Br J Rheumatol; 1996 Feb; 35(2):125-8. PubMed ID: 8612022
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of patients with axial and peripheral form of ankylosing spondylitis.
Mäki-Ikola O; Nissilä M; Lehtinen K; Leirisalo-Repo M; Toivanen P; Granfors K
Br J Rheumatol; 1995 May; 34(5):413-7. PubMed ID: 7788168
[TBL] [Abstract][Full Text] [Related]
4. Association of gut inflammation with increased serum IgA class Klebsiella antibody concentrations in patients with axial ankylosing spondylitis (AS): implication for different aetiopathogenetic mechanisms for axial and peripheral AS?
Mäki-Ikola O; Leirisalo-Repo M; Turunen U; Granfors K
Ann Rheum Dis; 1997 Mar; 56(3):180-3. PubMed ID: 9135221
[TBL] [Abstract][Full Text] [Related]
5. IgA class serum antibodies against three different Klebsiella serotypes in ankylosing spondylitis.
Mäki-Ikola O; Nissilä M; Lehtinen K; Granfors K
Br J Rheumatol; 1998 Dec; 37(12):1299-302. PubMed ID: 9973153
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in ankylosing spondylitis: effect of sulfasalazine treatment.
Nissilä M; Lahesmaa R; Leirisalo-Repo M; Lehtinen K; Toivanen P; Granfors K
J Rheumatol; 1994 Nov; 21(11):2082-7. PubMed ID: 7869314
[TBL] [Abstract][Full Text] [Related]
7. IgM, IgA and IgG class serum antibodies against Klebsiella pneumoniae and Escherichia coli lipopolysaccharides in patients with ankylosing spondylitis.
Mäki-Ikola O; Lehtinen K; Nissilä M; Granfors K
Br J Rheumatol; 1994 Nov; 33(11):1025-9. PubMed ID: 7981989
[TBL] [Abstract][Full Text] [Related]
8. Serum IgA1 and IgA2 subclass antibodies against collagens in patients with ankylosing spondylitis.
Tani Y; Sato H; Tanaka N; Mori K; Doida Y; Hukuda S
Scand J Rheumatol; 1997; 26(5):380-2. PubMed ID: 9385351
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of ankylosing spondylitis patients with/without iritis and enthesitis.
Mäki-Ikola O; Lehtinen K; Toivanen P; Granfors K
Br J Rheumatol; 1995 May; 34(5):418-20. PubMed ID: 7788169
[TBL] [Abstract][Full Text] [Related]
10. Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn's disease.
O'Mahony S; Anderson N; Nuki G; Ferguson A
Ann Rheum Dis; 1992 Dec; 51(12):1296-300. PubMed ID: 1485810
[TBL] [Abstract][Full Text] [Related]
11. Specific IgA subclass responses in serum and saliva: a 12-month follow-up study after parenteral booster immunization with tetanus toxoid.
Engström PE; Gustafson R; Granberg M; Engström GN
Acta Odontol Scand; 2002 Aug; 60(4):198-202. PubMed ID: 12222642
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow IgA and IgA subclass synthesis in ankylosing spondylitis.
Peeters AJ; Daha MR; Smeets TJ; Breedveld FC
J Rheumatol; 1992 May; 19(5):751-3. PubMed ID: 1613704
[TBL] [Abstract][Full Text] [Related]
13. Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease.
Cooper R; Fraser SM; Sturrock RD; Gemmell CG
Br Med J (Clin Res Ed); 1988 May; 296(6634):1432-4. PubMed ID: 3132277
[TBL] [Abstract][Full Text] [Related]
14. IgA antibodies to Klebsiella pneumoniae in ankylosing spondylitis.
Trull AK; Ebringer R; Panayi GS; Colthorpe D; James DC; Ebringer A
Scand J Rheumatol; 1983; 12(3):249-53. PubMed ID: 6353568
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
[TBL] [Abstract][Full Text] [Related]
16. [Antibodies to Klebsiella pneumoniae in ankylosing spondylitis].
Yuan GH; Shi GY; Ding YZ
Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):467-9. PubMed ID: 8275826
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis.
Ahmadi K; Wilson C; Tiwana H; Binder A; Ebringer A
Br J Rheumatol; 1998 Dec; 37(12):1330-3. PubMed ID: 9973159
[TBL] [Abstract][Full Text] [Related]
18. Bacterial antibodies in ankylosing spondylitis.
Mäki-Ikola O; Lehtinen K; Granfors K; Vainionpää R; Toivanen P
Clin Exp Immunol; 1991 Jun; 84(3):472-5. PubMed ID: 2044228
[TBL] [Abstract][Full Text] [Related]
19. Serum and secretory IgA immune response to Klebsiella pneumoniae in ankylosing spondylitis.
Trull AK; Panayi GS
Clin Rheumatol; 1983 Dec; 2(4):331-7. PubMed ID: 6430627
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the immune responses to collagens type I, III, IV and V and Klebsiella pneumoniae in patients with Crohn's disease and ankylosing spondylitis.
Tiwana H; Natt RS; Benitez-Brito R; Shah S; Wilson C; Bridger S; Harbord M; Sarner M; Ebringer A
Rheumatology (Oxford); 2001 Jan; 40(1):15-23. PubMed ID: 11157137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
